Molecular and cellular basis for adequate metabolic design of genotoxicity studies.
Genotoxic species and metabolites are usually under the control of a complex set of activating, inactivating and precursor sequestering enzymes. These enzymes differ greatly between test systems, animal species and man. An adequate metabolic design of genotoxicity studies requires careful attention to factors such as: Dilution of cofactors in in vitro tests which are present in much higher concentrations in the intact cell; Induction in high dose carcinogenicity bioassays of enzymes, which are constitutively not expressed and not induced at such doses of the compound, which occur in the situations of the practical use of the compound; Modifications of control enzymes, which are effected by hormones or other endogenous factors, which are differently influenced by high dose (bioassay) versus moderate dose (real exposure) or by in vivo (endocrine regulation) versus in vitro (no endocrine regulation) conditions.
Oesch
F
F
Institute of Toxicology, University of Mainz, Germany.
Oesch-Bartlomowicz
B
B
Arens
H J
HJ
Friedberg
T
T
Utesch
D
D
Glatt
H R
HR
Platt
K L
KL
D000818:Animals; D001551:Benz(a)Anthracenes / Q000378:metabolism / Q000633:toxicity; D001711:Biotransformation; D003994:Bucladesine / Q000494:pharmacology; D015197:Carcinogenicity Tests; D006801:Humans; D009152:Mutagenicity Tests; D009153:Mutagens / Q000378:metabolism* / Q000633:toxicity; D011494:Protein Kinases / Q000502:physiology
D001551:Benz(a)Anthracenes; D009153:Mutagens; D003994:Bucladesine; D011494:Protein Kinases